About Bulat Pharmaceutical
Bulat Pharmaceutical is a Healthcare company based in Gurugram (India) founded in 2017. Bulat Pharmaceutical produces APIs and intermediates for global pharmaceutical manufacturing needs. It operates on a B2B model. Its Indian entity Bulat Pharmaceutical Private Limited reported revenue of ₹1.52 Cr. Bulat Pharmaceutical offers products and services including APIs, Formulation, and Intermediates. Its focus areas include Pharmaceuticals, API Manufacturing and Drug Intermediates. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Bulat Pharmaceutical, founded in 2017 and based in Gurugram, Haryana, India, specializes in manufacturing and selling high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. The company conducts RD through a team of experts to ensure product excellence and focuses on improving processes for global clients. It serves various industries with reliable supply chain solutions and adheres to quality standards.
- Headquarters Gurugram, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bulatpharmaceutical.com
- Social X Facebook
- Legal Name Bulat Pharmaceutical Private Limited
- Date of Incorporation 23 Aug, 2017
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹1.52 Cr
FY 2019 · +31908% YoY
- Net Profit₹12.1 Lakh
FY 2019 · 8% margin
- EBITDA₹14 Lakh
FY 2019 · 9% margin
Associated legal entities of Bulat Pharmaceutical
Bulat Pharmaceutical operates through Bulat Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2019) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bulat Pharmaceutical Private Limited CIN U24304DL2017FTC322559 | Active | 23 Aug 2017 | New Delhi, Delhi | ₹1.5 Cr | 3 | View details |
Products & Services of Bulat Pharmaceutical
Bulat Pharmaceutical offers a comprehensive portfolio of products and services, including APIs, Formulation, and Intermediates.
High-quality active ingredients used in drug production
Formulated products including anti-malarial and anti-diabetic categories
Raw materials for synthesizing pharmaceutical APIs
Board of directors of Bulat Pharmaceutical Private Limited (Bulat Pharmaceutical)
Bulat Pharmaceutical Private Limited is the primary company behind Bulat Pharmaceutical. The board of Bulat Pharmaceutical Private Limited currently have 3 directors; the longest-serving is Li Qiang, appointed in 2017. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Li Qiang DIN 07839125 | Director | 23 Aug 2017 | 9 yrs 1 mo | Bulat Pharmaceutical Private Limited |
| Yu Zhang DIN 06429660 | Additional Director | 19 Apr 2021 | 5 yrs 6 mo | Bulat Pharmaceutical Private Limited |
| Saurabh Sharma DIN 09506674 | Director | 13 Jan 2025 | 1 yr 9 mo | Bulat Pharmaceutical Private Limited |
Financials of Bulat Pharmaceutical
Figures of Bulat Pharmaceutical Private Limited, the primary company behind Bulat Pharmaceutical, for FY 2019. Revenue was ₹1.52 Cr (+31908% year on year). Net profit was ₹12.1 Lakh (8% margin). EBITDA was ₹14 Lakh (9% margin).
- ₹1.52 CrRevenue · FY 2019 · +31908% YoY
- ₹12.1 LakhNet profit · 8% margin
- ₹14 LakhEBITDA · 9% margin
- ₹50 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Bulat Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Bulat Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Bulat Pharmaceutical
Bulat Pharmaceutical has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Bulat Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Bulat Pharmaceutical
The website of Bulat Pharmaceutical (bulatpharmaceutical.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 169.5% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Bulat Pharmaceutical
Bulat Pharmaceutical was founded in 2017.
Bulat Pharmaceutical is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
The primary company behind Bulat Pharmaceutical, Bulat Pharmaceutical Private Limited, reported revenue of ₹1.52 Cr for FY 2019, up 31908% year on year.
Bulat Pharmaceutical, founded in 2017 and based in Gurugram, Haryana, India, specializes in manufacturing and selling high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. The company conducts RD through a team of experts to ensure product excellence and focuses on improving processes for global clients. It serves various industries with reliable supply chain solutions and adheres to quality standards.
Bulat Pharmaceutical's top competitors include Laurus Labs, Symbiotec and SeQuent.
Bulat Pharmaceutical offers APIs, Formulation, and Intermediates.
Bulat Pharmaceutical operates through Bulat Pharmaceutical Private Limited.
The legal entities of Bulat Pharmaceutical currently have 3 directors, including Li Qiang, Yu Zhang, Saurabh Sharma.